Merck Tbk (MERK)

Jakarta

Currency in IDR

2,880

-10(-0.35%)

Closed·10:07:04

Fair Value

Unlock Value

Day's Range

2,840

2,900

52 wk Range

2,840

3,900

MERK Financial Summary

A brief financial summary of Merck Tbk as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio11.34

Price/Book1.98

Debt / Equity2.2%

Return on Equity17.44%

Dividend Yield5.88%

EBITDA218.50B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

655,847.13

1,064,394.82

1,124,599.74

961,433.97

1,036,747.71

Gross Profit

aa.aa

294,205.97

398,683.75

427,591.98

400,472.37

402,666.49

Operating Income

aa.aa

110,675.17

191,446.32

237,016.84

199,637.84

193,908.65

Net Income

aa.aa

71,902.26

131,660.83

179,837.76

178,240

153,463.42

Balance Sheet

Total Assets

aa.aa

929,901.05

1,026,266.87

1,037,647.24

957,814.11

956,936.73

Total Current Liabilities

aa.aa

266,348.14

282,931.35

239,074.43

125,031.38

108,891.46

Total Equity

aa.aa

612,683.03

684,043.79

757,241.65

795,878.79

807,273.56

Cash Flow

Levered Free Cash Flow

aa.aa

26,555.63

93,525.8

60,481.37

128,319.94

12,129.71

Cash from Operations

aa.aa

71,983.46

169,814.59

110,323.21

203,874.89

55,711.53

Cash from Investing

aa.aa

-31,421.07

-43,074.09

-19,997.73

-19,902.57

-16,672.27

Cash from Financing

aa.aa

-67,302.88

-65,122.83

-116,240.17

-152,963.79

-152,791.91

Net Change in Cash

aa.aa

-26,740.49

61,617.68

-25,914.69

31,008.52

-113,752.65

* In Millions of IDR (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 287.22%

Dividend Yield

5.88%

Industry Median 3.90%

Annualised payout

170.00

Paid annually

5-Years Growth

Growth Streak

Unlock

Earnings

Latest Release

May 06, 2025

EPS / Forecast

29.45 / --

Revenue / Forecast

215.16B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Merck's earnings for the latest quarter?

The Merck EPS (TTM) is 287.22. Merck reported sales of 215,161.23, net income of 13,193.85, and EPS of 29.45 for the latest quarter.

What was Merck's net income for the latest quarter?

Merck's net income for the latest quarter was 13,193.85.

How did Merck's performance compare year-over-year in the latest quarter?

The company's revenue moved from 283,009.83 in the previous quarter to 215,161.23 in the latest quarter, and net income moved from 76,405.94 to 13,193.85 compared to the previous quarter.

What is Merck's net profit margin on a TTM basis?

Merck's trailing twelve months (TTM) net profit margin is 14.80%.

How does Merck's debt to equity ratio compare to industry standards?

Merck's total debt-to-equity ratio is 2.20%.

What is Merck's return on investment on a TTM basis?

Merck's trailing twelve months (TTM) return on investment (ROI) is 17.44%.

Did Merck gain or lose cash last quarter?

In the latest quarter, Merck's net change in cash was 18,845.60 million.

What were Merck's total assets and liabilities in the latest quarter?

As of the latest quarter, Merck reported total assets of 982,689.92 million and total liabilities of 120,833.62 million.

How has Merck's total revenue grown this year?

Merck's total revenue was 283,009.83 in the previous quarter and 215,161.23 in the latest quarter.

What is Merck's gross margin on a TTM basis?

Merck's trailing twelve months (TTM) gross margin is 39.00%.

What was Merck's revenue per share for the latest quarter?

Merck's revenue per share for the latest quarter was 2,225.22.

NSE 30

5,330.45

+22.17

+0.42%

NSE All Share

145,567.34

+770.98

+0.53%

US 30

44,235.00

+123.3

+0.28%

US 500

6,309.10

+9.9

+0.16%

FTSE 100

9,165.85

+23.12

+0.25%

DAX

23,829.50

-27.69

-0.12%

South Africa Top 40

92,603.87

+408.37

+0.44%

Market Movers

Name	Last	Chg. %	Vol.
Sterling Bank	8.160	+9.97%	114.44M
Fidelitybk	21.350	-0.70%	39.46M
Zenith Bank	75.40	-0.66%	33.48M
UBA	48.40	-1.02%	11.76M
Lafarge Africa	146.50	0.00%	3.63M
BUA Cement	177.20	+3.93%	2.30M
Aradel Holdings	519.50	-0.10%	669.46K

Name	Last	Chg. %	Vol.
Mutual Benefits Assurance	2.42	+10.00%	2.57M
Nem	29.700	+10.00%	39.93K
Chellarams	11.55	+10.00%	22.04K
Guinness Nigeria	128.75	+10.00%	14.53K
Union Dicon Salt	9.90	+10.00%	16.40K
University Pre	5.610	+10.00%	113.67K
Mansard Ins	12.100	+10.00%	76.53K

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	1.32K
Total Nig	599.90	-6.27%	4.21K
Livingtrust Mortgage Bank	5.35	-9.93%	182.66K
Northern Nigeria Flour Mills	89.30	-4.13%	49.65K
UH REIT	58.00	-9.38%	4.89K
UAC Of Nigeria	92.10	-7.90%	985.03K
Conoil	217.50	-7.25%	308.90K

Trending Stocks

Name	Last	Chg. %	Vol.
BUA Cement	177.20	+3.93%	2.30M
MTN Nigeria	451.20	-6.00%	400.81K
UAC Of Nigeria	92.10	-7.90%	985.03K
Initiates	13.00	-7.14%	2.44M
Wema Bank	24.00	-3.23%	3.62M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaa	560.00	+30.87%	732.87
A Aaaaa Aaaaaaaa	67.90	+26.16%	85.66
Aaa Aaaa Aaa Aaaaaa	599.90	+16.74%	700.32

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Merck Tbk (MERK)

MERK Financial Summary

Key Ratios

Statements Highlights

Dividends

Earnings

FAQ

What were Merck's earnings for the latest quarter?

What was Merck's net income for the latest quarter?

How did Merck's performance compare year-over-year in the latest quarter?

What is Merck's net profit margin on a TTM basis?

How does Merck's debt to equity ratio compare to industry standards?

What is Merck's return on investment on a TTM basis?

Did Merck gain or lose cash last quarter?

What were Merck's total assets and liabilities in the latest quarter?

How has Merck's total revenue grown this year?

What is Merck's gross margin on a TTM basis?

What was Merck's revenue per share for the latest quarter?

Trending Stocks